Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dunkl LM"'
Autor:
Michowski W; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Chick JM; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Chu C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Kolodziejczyk A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Wang Y; School of Life Sciences, Peking University, Beijing 100871, China., Suski JM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Abraham B; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Anders L; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Day D; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Dunkl LM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Li Cheong Man M; Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3B2, Canada., Zhang T; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Laphanuwat P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Bacon NA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Liu L; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Fassl A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Sharma S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Otto T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Jecrois E; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Han R; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Sweeney KE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Marro S; Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology, Stanford University Medical School, Stanford, CA 94305, USA., Wernig M; Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology, Stanford University Medical School, Stanford, CA 94305, USA., Geng Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA., Moses A; Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3B2, Canada; Center for Analysis of Genome Evolution and Function, Toronto, ON M5S 3B2, Canada., Li C; School of Life Sciences, Peking University, Beijing 100871, China., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Young RA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Sicinski P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address: peter_sicinski@dfci.harvard.edu.
Publikováno v:
Molecular cell [Mol Cell] 2020 May 07; Vol. 78 (3), pp. 459-476.e13. Date of Electronic Publication: 2020 Apr 01.
Autor:
Lu H; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Liu C; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Velazquez R; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Wang H; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Dunkl LM; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Kazic-Legueux M; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Haberkorn A; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Billy E; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Manchado E; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Brachmann SM; Novartis Institutes for BioMedical Research, Oncology Disease Area, Novartis Pharma AG, Basel, Switzerland., Moody SE; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Engelman JA; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Hammerman PS; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Caponigro G; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Mohseni M; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts., Hao HX; Novartis Institutes for BioMedical Research, Oncology Disease Area, Cambridge, Massachusetts. huaixiang.hao@novartis.com.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2019 Jul; Vol. 18 (7), pp. 1323-1334. Date of Electronic Publication: 2019 May 08.